UK Companies House feature
GLAXOSMITHKLINE IHC LIMITED
Profile
- Company number
- 07257967
- Status
- Active
- Incorporation
- 2010-05-18
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 64999
- Hubs
- UK Fintech
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WHYTE, Victoria Anne | Secretary | 2010-05-18 | — | — |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2010-05-18 | — | — |
| DAVIDSON, Alistair Robert | Director | 2020-09-17 | Dec 1972 | British |
| WALKER, Adam | Director | 2015-06-17 | Nov 1967 | British |
| WOODTHORPE, Timothy John | Director | 2023-12-06 | Jan 1979 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLACKBURN, Paul Frederick | Director | 2010-05-18 | 2016-03-01 |
| BORGER, James | Director | 2019-02-25 | 2020-03-02 |
| BURNS, Alan George | Director | 2012-12-03 | 2019-04-03 |
| DAVIES, Derek | Director | 2010-08-16 | 2012-12-14 |
| DUBIANSKIJ, Oleg | Director | 2017-01-31 | 2019-02-13 |
| GRIST, Ashley Alexander | Director | 2010-05-18 | 2010-10-20 |
| LYNCH, Ciara Martha | Director | 2020-03-02 | 2020-11-09 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2010-05-18 | 2023-12-06 |
| GLAXO GROUP LIMITED | Corporate Director | 2010-05-18 | 2023-12-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Glaxosmithkline Finance Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 65 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-27 | CH01 | officers | change person director company with change date |
| 2025-09-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-28 | AA | accounts | accounts with accounts type full |
| 2024-11-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-23 | CH03 | officers | change person secretary company with change date |
| 2024-09-17 | CH01 | officers | change person director company with change date |
| 2024-09-17 | CH01 | officers | change person director company with change date |
| 2024-09-17 | CH01 | officers | change person director company with change date |
| 2024-09-11 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2024-09-11 | AD01 | address | change registered office address company with date old address new address |
| 2024-08-16 | AA | accounts | accounts with accounts type full |
| 2024-07-18 | AD02 | address | change sail address company with new address |
| 2023-12-08 | AP01 | officers | appoint person director company with name date |
| 2023-12-06 | TM01 | officers | termination director company with name termination date |
| 2023-12-06 | TM01 | officers | termination director company with name termination date |
| 2023-10-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-16 | CH02 | officers | change corporate director company with change date |
| 2023-07-24 | AA | accounts | accounts with accounts type full |
| 2022-10-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-06-15 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.